Medicinova (MNOV) Income Statement

Click line-items for a historical chart and %

Revenues
Cost of revenues
Research and development
General and administrative	1.96M
Total operating expenses	2.84M
Operating loss	-2.84M
Write-off of debt related costs
Gain/(impairment charge) on investment securities
Foreign exchange gain/(loss)
Other expense	-2.78K
Interest expense
Other income	13.39K
Income taxes	-1.68K
Net loss	-2.84M
Accretion to redemption value of redeemable convertible preferred stock
Deemed dividend resulting from beneficial conversion feature on Series C redeemable convertible preferred stock
Net loss applicable to common stockholders
Basic and diluted net loss per common share	-0.08
Shares used to compute basic and diluted net loss per common share

Entities mentioned with MNOV

View All Entities